Other equities research analysts also recently issued research reports about the company. Dundee Securities restated a neutral rating and set a C$20.00 price target on shares of Jean Coutu Group PJC in a research report on Thursday, September 22nd. TD Securities restated a reduce rating and set a C$17.50 price target on shares of Jean Coutu Group PJC in a research report on Wednesday, June 29th. Royal Bank Of Canada raised their price target on Jean Coutu Group PJC from C$19.00 to C$20.00 and gave the company a sector perform rating in a research report on Wednesday, September 28th. Finally, CIBC restated a sector perform rating and set a C$19.00 price target on shares of Jean Coutu Group PJC in a research report on Wednesday, July 6th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the company. Jean Coutu Group PJC presently has a consensus rating of Hold and an average target price of C$19.31.
Jean Coutu Group PJC Company Profile
The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.
Receive News & Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related companies with MarketBeat.com's FREE daily email newsletter.